Published in J Biol Chem on December 20, 2013
The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines. Sci Rep (2015) 1.40
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med (2016) 1.32
Whole-genome mutational burden analysis of three pluripotency induction methods. Nat Commun (2016) 0.93
Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review. JAMA Cardiol (2016) 0.86
Distinct Metabolic States Can Support Self-Renewal and Lipogenesis in Human Pluripotent Stem Cells under Different Culture Conditions. Cell Rep (2016) 0.79
Reprogramming of Pancreatic Exocrine Cells AR42J Into Insulin-producing Cells Using mRNAs for Pdx1, Ngn3, and MafA Transcription Factors. Mol Ther Nucleic Acids (2016) 0.79
Attenuated Innate Immunity in Embryonic Stem Cells and Its Implications in Developmental Biology and Regenerative Medicine. Stem Cells (2015) 0.78
Patient-derived induced pluripotent stem cells in cancer research and precision oncology. Nat Med (2016) 0.77
The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases. Curr Protoc Toxicol (2016) 0.76
Genetic stability of pluripotent stem cells during anti-cancer therapies. Exp Ther Med (2016) 0.76
Reducing genomic instability in iPSCs. Oncotarget (2015) 0.76
Using Stem Cells to Grow Artificial Tissue for Peripheral Nerve Repair. Stem Cells Int (2016) 0.75
Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis. PLoS One (2017) 0.75
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease. Sci Rep (2016) 0.75
Introduction to thematic minireview series: Development of human therapeutics based on induced pluripotent stem cell (iPSC) technology. J Biol Chem (2013) 0.75
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells. PLoS Genet (2017) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med (2004) 8.89
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell (2011) 8.21
Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med (2006) 7.21
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature (2005) 6.95
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell (2011) 6.82
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol (2007) 4.53
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Chromosome instability is common in human cleavage-stage embryos. Nat Med (2009) 3.85
Mosaic copy number variation in human neurons. Science (2013) 3.57
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09
Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol (2005) 3.03
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94
Somatic mutation, genomic variation, and neurological disease. Science (2013) 2.72
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell (2011) 2.71
A genomic view of mosaicism and human disease. Nat Rev Genet (2013) 2.67
Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol (2009) 2.66
Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet (2005) 2.66
Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle (2009) 2.30
Constitutional aneuploidy in the normal human brain. J Neurosci (2005) 2.28
Chromosomal variation in neurons of the developing and adult mammalian nervous system. Proc Natl Acad Sci U S A (2001) 2.20
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell (2012) 2.11
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med (2013) 2.10
The biotech death of Jesse Gelsinger. N Y Times Mag (1999) 2.03
Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability. Cell Stem Cell (2010) 2.02
Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol (2011) 1.98
High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly. J Neurosci (2006) 1.89
Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol (2011) 1.85
Genetics. Genome mosaicism--one human, multiple genomes. Science (2013) 1.82
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One (2011) 1.75
Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet (1992) 1.70
Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci U S A (2012) 1.62
Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells (2012) 1.62
Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci (2004) 1.56
Specific chromosome change, i(12p), in testicular tumours? Lancet (1982) 1.52
The variation of aneuploidy frequency in the developing and adult human brain revealed by an interphase FISH study. J Histochem Cytochem (2005) 1.42
Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease. Stem Cells (2012) 1.41
Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells (2008) 1.38
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet (2009) 1.36
Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
Transposition-driven genomic heterogeneity in the Drosophila brain. Science (2013) 1.35
The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke (2009) 1.32
Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility. Hum Mol Genet (2011) 1.31
Concise review: Genomic stability of human induced pluripotent stem cells. Stem Cells (2012) 1.29
Alteration of gene expression by chromosome loss in the postnatal mouse brain. J Neurosci (2003) 1.28
New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res (2002) 1.25
Nonrandom abnormalities in chromosome 1 in human testicular cancers. Cancer Res (1980) 1.11
Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One (2011) 1.10
Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal. Stem Cell Res (2011) 1.07
Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer (2008) 1.05
Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer (1993) 1.04
Genomic stability in reprogramming. Curr Opin Genet Dev (2012) 1.02
Elucidating the origin of chromosomal aberrations in IVF embryos by preimplantation genetic analysis. Mol Cell Endocrinol (2007) 0.98
Aneuploidy and early human embryo development. Hum Mol Genet (2008) 0.97
Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis. Lab Invest (2000) 0.95
Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells. J Clin Invest (2012) 0.95
Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About? Curr Genomics (2010) 0.94
Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J Pathol (2000) 0.91
Chimerism in monochorionic dizygotic twins: case study and review. Am J Med Genet A (2013) 0.90
In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells (2012) 0.88
Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Padiatr (2001) 0.87
LINE-1: creators of neuronal diversity. Front Biosci (Elite Ed) (2012) 0.85
Numerical chromosome variation and mitotic segregation defects in the adult brain of teleost fish. Dev Neurobiol (2007) 0.84
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol (2012) 7.37
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell (2011) 6.82
Regulatory networks define phenotypic classes of human stem cell lines. Nature (2008) 4.98
A bioinformatic assay for pluripotency in human cells. Nat Methods (2011) 3.66
Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell (2011) 3.32
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A (2009) 2.96
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94
Human embryonic stem cells have a unique epigenetic signature. Genome Res (2006) 2.89
Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells (2008) 2.52
A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell (2011) 2.48
Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability. Cell Stem Cell (2010) 2.02
Gene therapy: can neural stem cells deliver? Nat Rev Neurosci (2006) 1.95
A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell (2010) 1.93
Conversion of human fibroblasts to angioblast-like progenitor cells. Nat Methods (2012) 1.91
Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. J Neurosci (2003) 1.76
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One (2011) 1.75
Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol (2006) 1.58
Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58
Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell (2008) 1.57
Induced pluripotent stem cells from highly endangered species. Nat Methods (2011) 1.24
The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol (2012) 1.23
Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res (2011) 1.17
Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology (2006) 1.15
Differentiation of neural lineage cells from human pluripotent stem cells. Methods (2008) 1.13
DNA methylation in embryonic stem cells. J Cell Biochem (2010) 1.11
Epigenetic therapy for Friedreich ataxia. Ann Neurol (2014) 1.11
Highly parallel genome-wide expression analysis of single mammalian cells. PLoS One (2012) 1.10
Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One (2011) 1.10
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev (2005) 1.08
BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ΔNp63+ cytotrophoblast stem cell state. Development (2013) 1.07
Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Res Ther (2014) 1.05
Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Curr Protoc Stem Cell Biol (2007) 1.04
Restricted ethnic diversity in human embryonic stem cell lines. Nat Methods (2010) 1.02
Transcriptome coexpression map of human embryonic stem cells. BMC Genomics (2006) 1.01
Beyond fraud--stem-cell research continues. N Engl J Med (2006) 1.00
Preparation of autogenic human feeder cells for growth of human embryonic stem cells. Curr Protoc Stem Cell Biol (2008) 0.98
Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells. PLoS One (2011) 0.92
Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev (2011) 0.92
Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. J Cell Sci (2013) 0.92
The ACTCellerate initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives. Regen Med (2008) 0.91
Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. Ann N Y Acad Sci (2002) 0.89
Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells (2006) 0.88
Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state. PLoS One (2011) 0.85
Propagation of human embryonic and induced pluripotent stem cells in an indirect co-culture system. Biochem Biophys Res Commun (2010) 0.83
A role for stem cell biology in the physiological and pathological aspects of aging. J Am Geriatr Soc (2005) 0.83
A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells. Neuro Oncol (2010) 0.80
Melanocytes derived from transgene-free human induced pluripotent stem cells. J Invest Dermatol (2013) 0.80
Equally potent? Does cellular reprogramming justify the abandonment of human embryonic stem cells? EMBO Rep (2012) 0.79
Teratoma generation in the testis capsule. J Vis Exp (2011) 0.77
Intraspinal transplantation of mouse and human neural precursor cells. Curr Protoc Stem Cell Biol (2013) 0.77
The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine. Expert Opin Biol Ther (2015) 0.76
A modest proposal in response to Rhodes and Schiano. Am J Bioeth (2010) 0.75
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies. Expert Rev Neurother (2014) 0.75
Growth of an industry: how U.S. scientists and clinicians have enabled stem cell tourism. Am J Bioeth (2010) 0.75
Ethnically diverse pluripotent stem cells for drug development. Trends Mol Med (2012) 0.75
Stem cell reprogramming: basic implications and future perspective for movement disorders. Mov Disord (2014) 0.75